SLC6A3 and attention deficit-hyperactivity disorder: Individuals carrying DAT 10/10 genotype exhibited higher DAT auto-antibodies levels than healthy controls which correlated with disease severity↓ DAT auto-antibody levels comparable to healthy controls in ADHD patients treated with methylphenidate